EC
CALA

EcoR1 Capital’s Calithera Biosciences, Inc CALA Stock Holding History

EcoR1 Capital’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,774
Closed -$3.18M – 43
2015
Q4 		$3.18M Hold
20,774
– – 1% 23
2015
Q3 		$2.26M Hold
20,774
– – 1.03% 19
2015
Q2 		$2.97M Buy
20,774
+6,000
+41% +$1.39M 0.99% 17
2015
Q1 		$4.85M Buy
14,774
+4,689
+46% +$1.67M 1.62% 18
2014
Q4 		$4.07M Buy
+10,085
New +$2.63M 2.06% 15

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital's CALA Position: Q1 2016 in Review

EcoR1 Capital sold out of Calithera Biosciences, Inc (CALA) in Q1 2016, closing a stake of 20,774 shares — an estimated $3.18M sold.

EcoR1 Capital first reported a position in CALA in Q4 2014 and held it in 5 quarters. The position peaked at $4.85M in Q1 2015. 52 funds tracked by Wall St. Rank hold CALA as of Q1 2016.

  • EcoR1 Capital reported no remaining Calithera Biosciences, Inc position as of Q1 2016 after selling out during the quarter.
  • EcoR1 Capital sold 20,774 Calithera Biosciences, Inc shares in Q1 2016, an estimated $3.18M.
  • EcoR1 Capital first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 5 quarters.
  • EcoR1 Capital's Calithera Biosciences, Inc position peaked at $4.85M in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2016.

Based on EcoR1 Capital's 13F filing for Q1 2016, filed 16 May 2016.